Comprehensive Medical Oncology Review Course (v5.1)

Release Date: October 14, 2020 | Termination Date: October 13, 2023

Getting Started

To access the course materials, download the compressed (.rar) files and place them in the same folder on your computer. Extract the file part1.rar using WinRAR, which will automatically extract all other parts together. Once extracted, run the medical-oncology-review-(v5.1).html file to begin the lecture. A complete syllabus is available as a separate PDF file for your reference.

High-Yield Content for Medical Oncology Certification

This comprehensive library of video lectures is precisely aligned to the Medical Oncology Certification and Medical Oncology MOC exam blueprints, ensuring you focus on all exam topics and keywords with no wasted effort. Our board-certified faculty are experienced in teaching Medical Oncology board exam preparation, making every lecture up-to-date, medically accurate, and entirely board-relevant.

Study Guide and Intended Audience

A detailed PDF study guide is included with the course, providing a complete syllabus and hundreds of pages of valuable resources. This course is designed for oncologists seeking to advance their knowledge and skills in Medical Oncology.

Learning Objectives

Upon completion of this program, participants should be able to:

• Assess diagnosis, staging, and prognostic factors of breast cancer.
• Explain the different types of gynecologic cancer.
• Describe basic pharmacological and biological principles in the management and treatment of cancer.
• Develop comprehensive management and treatment plans for genitourinary cancer, including bladder, other urothelial, prostate, and renal cancer, and germ cell tumors.
• Demonstrate medical management of lung and thymic cancer and mesothelioma.
• Integrate modalities of care and ethics, including treatment-related issues, complications, supportive care, survivorship, psychosocial aspects of cancer, bioethical/legal/economic issues, and communication skills.

Course Content Overview

The comprehensive course covers a wide range of topics in Medical Oncology, including:

Hematologic Neoplasms

• Acute Leukemia and Myelodysplasia (1 Hour) – Peter Silberstein, MD
• Chronic Myeloid Leukemia and Myeloproliferative Neoplasms (1 Hour) – Peter Silberstein, MD
• Chronic Lymphoproliferative Leukemias (0.5 Hours) – Peter Silberstein, MD
• Multiple Myeloma and Plasma Cell Dyscrasias (1 Hour) – Peter Silberstein, MD
• Non-Hodgkin Lymphoma (1.5 Hours) – Peter Silberstein, MD

Thoracic Cancer

• Non-small Cell Lung Cancer (0.5 Hours) – Christine M. Bestvina, MD
• Small Cell Lung Cancer and Mesothelioma and Thymus Cancer (0.25 Hour) – Christine M. Bestvina, MD

Breast Cancer

• Premalignant Conditions, High-risk Factors & Carcinoma in Situ (0.5 Hours) – Skikha Jain, MD
• Early-Stage Invasive Carcinoma (0.75 Hours) – Jacob Thomas, MD
• Less Common Histologies and Clinical Scenarios (0.25 Hours) – Jacob Thomas, MD
• Locally Advanced and Inflammatory Disease and Locally Recurrent Disease (0.25 Hours) – Jacob Thomas, MD
• Metastatic Disease (1 Hour) – Jacob Thomas, MD

Genitourinary Cancer

• Germ Cell Tumors (0.25 Hours) – Skikha Jain, MD
• Prostate Cancer (0.75 Hours) – Skikha Jain, MD
• Renal Cell Cancer (0.5 Hours) – Skikha Jain, MD
• Urothelial and other Genitorourinary Cancers (1 Hour) – Skikha Jain, MD

Gynecologic Cancer

• Cancer of the Cervix, Vulva, & Vagina & Other Gynecologic Malignancies (0.5 Hours) – Peter Silberstein, MD
• Ovarian Cancer (1 Hour) – Peter Silberstein, MD

Gastrointestinal Cancer

• Gastrointestinal: Pancreatic & Anal Cancer (1 Hour) – Efrat Dotan, MD
• Gastrointestinal: Biliary/Gallbladder Cancer & Neuroendocrine Tumors (0.75 Hours) – Efrat Dotan, MD
• Gastrointestinal: Colorectal Cancer (1.5 Hours) – Efrat Dotan, MD
• Gastrointestinal: Gastric Cancer (1 Hour) – Efrat Dotan, MD
• Gastrointestinal: Esophageal Cancer (0.75 Hours) – Efrat Dotan, MD
• Gastrointestinal: Hepatocellular Carcinoma (0.5 Hours) – Efrat Dotan, MD

Skin Cancer, Sarcomas, and Unknown Primary Site

• Bone and Soft Tissue Sarcomas and Unknown Primary Site Part I (0.5 Hours) – Peter Silberstein, MD
• Unknown Primary Site Part II (0.5 Hours) – Peter Silberstein, MD
• Melanoma and Other Skin Cancers (0.75 Hours) – Jacob Thomas, MD

Anticancer Therapeutics, Clinical Research Methodology, and Ethics

• Anticancer Therapeutics (2.25 Hours) – Jacob Thomas, MD
• Clinical Research Methodology and Ethics (0.5 Hours) – Jacob Thomas, MD
• Principles of Allied Disciplines (0.75 Hours) – Jacob Thomas, MD

Palliative Care, Survivorship, and Communication

• Cancer Pain I (0.5 Hours) – Jacob Thomas, MD
• Cancer Pain II and Survivorship Issues (0.5 Hours) – Jacob Thomas, MD
• Clinical Manifestations of Advanced Cancer and Its Treatment (1.5 Hours) – Peter Silberstein, MD
• End-of-Life Issues (0.5 Hours) – Peter Silberstein, MD
• Procedure-related Issues and Communication (0.5 Hours) – Peter Silberstein, MD

Head, Neck, Thyroid, and Central Nervous System Malignancies

• Head & Neck Cancer (1.5 Hours) – Ari Rosenberg, MD
• Thyroid and Salivary Gland Cancer (0.5 Hours) – Ari Rosenberg, MD
• Central Nervous System Malignancies (0.5 Hours) – Ari Rosenberg, MD

Genetics and Tumor Biology

• Cancer Biology, Genetics, and Tumor Immunology (0.75 Hours) – Akash Patnaik, MD
• Heritable Cancer Syndromes and Cancer Epidemiology (0.5 Hours) – Akash Patnaik, MD